We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pfizer Sues Teva Over Lipitor Patent

Law360 (June 8, 2007, 12:00 AM EDT) -- Pharmaceutical giant Pfizer Inc. filed suit Thursday against Teva Pharmaceuticals USA Inc., claiming the generics maker infringed a patent for its cholesterol-lowering drug Lipitor with its latest abbreviated new drug application.

The complaint was filed by Pfizer and its subsidiary Warner-Lambert Co. in the U.S. District Court for the District of Delaware. Warner-Lambert, which merged with Pfizer in 2000, is the owner of the patent-in-suit, U.S. Patent Number 5,273,995.

The ‘995 patent describes atorvastatin calcium, a key ingredient in Lipitor. The patent does not expire until...
To view the full article, register now.